Autonomix Medical (NASDAQ:AMIX) Announces Earnings Results

Autonomix Medical (NASDAQ:AMIX) posted its quarterly earnings data on Wednesday. The company reported ($1.38) earnings per share for the quarter, Zacks reports.

Autonomix Medical Stock Performance

Shares of NASDAQ:AMIX traded up $0.01 during trading on Friday, reaching $0.74. 108,503 shares of the stock were exchanged, compared to its average volume of 569,132. Autonomix Medical has a 12-month low of $0.69 and a 12-month high of $14.06. The firm has a market cap of $4.61 million, a price-to-earnings ratio of -0.16 and a beta of -2.76. The firm’s 50-day moving average price is $1.07 and its 200 day moving average price is $1.34.

Analyst Ratings Changes

AMIX has been the subject of several analyst reports. Wall Street Zen raised Autonomix Medical to a “sell” rating in a research note on Saturday, July 26th. Weiss Ratings reissued a “sell (e+)” rating on shares of Autonomix Medical in a research report on Wednesday, October 8th. Finally, Zacks Research downgraded Autonomix Medical from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 28th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $5.00.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.